KC
Kevin Charles Gorman
DELAYED 1 MONTH
Director
NEUROCRINE BIOSCIENCES INC
Filings
2
Companies
1
Latest
May 27, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
75
NEUROCRINE BIOSCIENCES INC
Kevin Charles Gorman
Director
Sale
$37.8M
245,088 sh
May 21 9:49 PM
May 19, 2026
—
NEUROCRINE BIOSCIENCES INC
Kevin Charles Gorman
Director
Option Exercise
$8.9M
205,088 sh
May 21 9:49 PM
May 19, 2026